CAROL ISENBERG: Open Payments
NPI 1508121575 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,906 in 89 payments from 20 companies in 2025. Trend: 2023 $1,606 · 2024 $1,567 · 2025 $1,906
Food & beverage: $1,811Education: $95
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $346 |
| Novartis Pharmaceuticals Corporation | 10 | $189 |
| ABBVIE INC. | 9 | $160 |
| GENZYME CORPORATION | 5 | $159 |
| Janssen Biotech, Inc. | 6 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $128 |
| Lilly USA, LLC | 8 | $114 |
| UCB, Inc. | 5 | $113 |
| Amgen Inc. | 5 | $95 |
| LEO Pharma Inc. | 5 | $87 |
Products named: DUPIXENT, ILUMYA, TREMFYA, COSENTYX, EBGLYSS, Bimzelx, RINVOQ, OTEZLA.
Industry payments across GA — which companies pay providers there.
